Takeda Pharmaceutical Company Limited American Depositary Shares (each r (TAK) Covered Calls

You can sell covered calls on Takeda Pharmaceutical Company Limited American Depositary Shares (each r to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TAK (prices last updated Fri 4:16 PM ET):

Takeda Pharmaceutical Company Limited American Depositary Shares (each r (TAK) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
14.33	-0.06	14.10	14.49	2.1M	-	0.0

Covered Calls For Takeda Pharmaceutical Company Limited American Depositary Shares (each r (TAK)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Dec 19	15	0.00	14.49	0.0%	0.0%
Jan 16	15	0.05	14.44	0.3%	3.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a corporate strategic research alliance with Egle Therapeutics SAS; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.

Top 10 Open Interest For Dec 19 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	EEM covered calls	1.	NKTR covered calls
2.	SPY covered calls	7.	TLT covered calls	2.	AVXL covered calls
3.	IBIT covered calls	8.	SLV covered calls	3.	CTMX covered calls
4.	IWM covered calls	9.	NFLX covered calls	4.	BE covered calls
5.	QQQ covered calls	10.	TSLA covered calls	5.	OMER covered calls

Want more examples? TAIL Covered Calls | TAL Covered Calls